1Suppliers
1Customers
1Debt Items
11Related Chains

Immuron Limited Suppliers

TickerNameConfidenceEvidence
PHARMARON-CPC-INC PHARMARON-CPC-INC 90% On October 4, 2022, Immuron announced execution of a clinical trial master service agreement with Maryland, Baltimore, USA based Pharmaron CPC, Inc.

Immuron Limited Customers

TickerNameConfidenceEvidence
SYNLAIT-MILK-LIMITED SYNLAIT-MILK-LIMITED 85% harmed and our ability to generate product revenues from any of these product candidates will be delayed or eliminated. Any of these occurrences may harm our business, financial condition and prospec…

Immuron Limited Debt Obligations

InstrumentDescriptionConfidenceEvidence
IMRN-DEBT Debt stack $145,538 90% Market cache reports total debt of $145,538.

Immuron Limited Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Immuron Limited.

Immuron Limited Ownership

HolderNameConfidenceEvidence
IMRN-OWNER-MORGAN-STANLEY MORGAN STANLEY 90% 13F overlay lists MORGAN STANLEY as top holder; 7 tracked holders.

Immuron Limited Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
TVTX Travere Therapeutics, Inc. 100.00 2
SIGA SIGA Technologies, Inc. 100.00 2
TLSA Tiziana Life Sciences Ltd 100.00 2
CRDF Cardiff Oncology, Inc. 100.00 2
HEPA Hepion Pharmaceuticals, Inc. 100.00 2
VXRT Vaxart, Inc. 50.00 2
HAE Haemonetics Corporation 50.00 2
ARCT Arcturus Therapeutics Holdings Inc. 50.00 2
TMC TMC the metals company Inc. 50.00 2
CSLLY CSL Limited 38.88 1 ['receiving']
OKYO OKYO Pharma Limited 36.29 1 ['spend']